HCPS

TransUnion Announces Improved Health Audiences to Power Effective Advertising on Connected TV and Streaming Audio

Retrieved on: 
Thursday, November 10, 2022

The announcement comes at a time when pharmaceutical and medical advertising is flourishing, ranked second among advertising verticals in 2021 with $5.6 billion spent in the U.S .

Key Points: 
  • The announcement comes at a time when pharmaceutical and medical advertising is flourishing, ranked second among advertising verticals in 2021 with $5.6 billion spent in the U.S .
  • Veeva Crossix Audience Segments are the industrys most widely used, data-driven segments that help brands reach relevant health audiences at scale.
  • Our collaboration with Veeva Crossix enables best-in-class data for direct and programmatic marketing across connected TV and streaming audio with unprecedented scale.
  • According to our Trends in Health Advertising Report , streaming video now accounts for 8% of Veeva Crossix clients digital media mix and streaming audio impressions have grown 61% year-over-year.

CMI Media Group Launches Ecommerce Practice for Pharma and Healthcare Clients

Retrieved on: 
Thursday, November 10, 2022

PHILADELPHIA, Nov. 10, 2022 /PRNewswire-PRWeb/ -- CMI Media Group, a WPP company (NYSE: WPP) continues to evolve its solution suite to address the ever-shifting healthcare consumption habits and needs of consumers, patients and HCPs, through the launching of a healthcare focused ecommerce practice. The ecommerce offering will keep CMI Media Group on the cutting edge of direct-to-consumer marketing, connecting life sciences, medtech and healthcare clients to audiences ready to buy. The company has established branding partnerships with Ecommerce leaders including Amazon, Target, Walmart and other industry leaders.

Key Points: 
  • The ecommerce offering will keep CMI Media Group on the cutting edge of direct-to-consumer marketing, connecting life sciences, medtech and healthcare clients to audiences ready to buy.
  • PHILADELPHIA, Nov. 10, 2022 /PRNewswire-PRWeb/ -- CMI Media Group, a WPP company (NYSE: WPP) continues to evolve its solution suite to address the ever-shifting healthcare consumption habits and needs of consumers, patients and HCPs, through the launching of a healthcare focused ecommerce practice.
  • The ecommerce offering will keep CMI Media Group on the cutting edge of direct-to-consumer marketing, connecting life sciences, medtech and healthcare clients to audiences ready to buy.
  • As the leading media resource for the world's top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients.

Aktana Named Trailblazer in Commercial Analytics & AI Assessment by Everest Group

Retrieved on: 
Wednesday, November 9, 2022

Aktana , the leader in intelligent customer engagement for the global life sciences industry, today announced being named a trailblazer in Everest Groups assessment report, Life Sciences Commercial Analytics & AI Trailblazers. "

Key Points: 
  • Aktana , the leader in intelligent customer engagement for the global life sciences industry, today announced being named a trailblazer in Everest Groups assessment report, Life Sciences Commercial Analytics & AI Trailblazers. "
  • "Aktana has been leading and defining the category for more than a decade," said Derek Choy, president of Aktana.
  • Aktana has emerged as a trailblazer in commercial life sciences analytics and AI from more than 300 deployments across 50+ use cases.
  • "Aktana offers an AI-based platform and a suite of modular solutions to help life sciences enterprises with hyper-personalized customer engagement, customer journey management, and cognitive intelligence spanning the entire commercial function, thus resulting in it being featured as a trailblazer in Life Sciences Commercial Analytics & AI Trailblazers assessment.

CMI Media Group Bolsters Innovative Capabilities with Audience Intelligence Group for Pharma and Healthcare Clients

Retrieved on: 
Tuesday, November 8, 2022

PHILADELPHIA, Nov. 8, 2022 /PRNewswire-PRWeb/ -- CMI Media Group, a WPP company (NYSE: WPP), has evolved its Audience Intelligence practice to holistically connect audience strategy, marketing/ad research, social intelligence, and data insights further enabling always on-intelligence that drives dynamic content, media-mix optimization and deeper engagements. With a focus on driving clients towards where innovation and data intersect, this forward-thinking mentality will continue to position the company as the leader in precisely human insight and activation. The company has made several key hires and promotions to support the practice.

Key Points: 
  • PHILADELPHIA, Nov. 8, 2022 /PRNewswire-PRWeb/ -- CMI Media Group, a WPP company (NYSE: WPP), has evolved its Audience Intelligence practice to holistically connect audience strategy, marketing/ad research, social intelligence, and data insights further enabling always on-intelligence that drives dynamic content, media-mix optimization and deeper engagements.
  • "Our industry often talks about improving patient outcomes and in evolving our Audience Intelligence group we've been able to walk the walk.
  • CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com ), is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing.
  • As the leading media resource for the world's top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients.

Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, November 7, 2022

Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of todays women.

Key Points: 
  • Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of todays women.
  • Twirla is based on our proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.
  • Unless otherwise noted, the prescription data results reported in this press release are reported as of September 30, 2022, by Symphony Health Solutions.
  • For all these reasons, actual results and developments could be materially different from those expressed in or implied by our forward-looking statements.

Verana Health to Present Findings of Diabetic Retinopathy Study Using American Academy of Ophthalmology IRIS® Registry Data at AMIA Annual Symposium

Retrieved on: 
Monday, November 7, 2022

The title of the study described in the poster is " Understanding Mechanisms of Missingness for Unspecified Diabetic Retinopathy Disease Severity in the Electronic Health Record: An IRIS Registry Analysis."

Key Points: 
  • The title of the study described in the poster is " Understanding Mechanisms of Missingness for Unspecified Diabetic Retinopathy Disease Severity in the Electronic Health Record: An IRIS Registry Analysis."
  • Established in 2014, the IRIS Registry is one of the largest specialty society clinical data registries in all of medicine.
  • The results of this study suggest that diabetic retinopathy disease severity is likely MNAR in the electronic health record.
  • Using its clinician-informed and artificial intelligence-enhanced VeraQpopulation health data engine, Verana Health transforms structured and unstructured healthcare data into curated, disease-specific data modules, Qdata.

New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe

Retrieved on: 
Thursday, November 3, 2022

The average person sees their pharmacists nearly 12 times more frequently than their HCPs, creating an enormous opportunity to bridge current gaps in the healthcare system.

Key Points: 
  • The average person sees their pharmacists nearly 12 times more frequently than their HCPs, creating an enormous opportunity to bridge current gaps in the healthcare system.
  • According to previous research, only 25% of those eligible for PrEP actually receive it, despite its strong efficacy.
  • A few states currently allow pharmacists to prescribe other medications, including birth control, smoking cessation medications, and medications for conditions such as asthma and diabetes.
  • When access improves, as we saw with this study, so does adherence, said Tori Marsh, MPH, Director of Research at GoodRx.

READY, HEALTHY & ABLE: HealthyWomen Launches New Program to Provide Servicewomen and Healthcare Providers Content and Resources to Take Control of Their Health

Retrieved on: 
Thursday, November 3, 2022

The U.S. military has never before had a higher percentage of women, yet military healthcare services have not evolved to reflect this changing population.

Key Points: 
  • The U.S. military has never before had a higher percentage of women, yet military healthcare services have not evolved to reflect this changing population.
  • The first phase of the Ready, Healthy & Able program will address this lack of gender-specific healthcare resources, especially in the areas of reproductive, urologic and mental health.
  • Elevate understanding and awareness of women's health conditions and women-focused healthcare services within the military branches among servicewomen and service members with female biology.
  • In addition to direct outreach to servicewomen and service members with female biology, this program also aims to provide the military healthcare community with the resources it needs to provide optimal care.

Verana Health to Present Findings of Studies Using American Academy of Ophthalmology IRIS® Registry Data to Advance Insights into Real World Outcomes in Treating AMD

Retrieved on: 
Wednesday, November 2, 2022

SAN FRANCISCO, Nov. 2, 2022 /PRNewswire/ -- During The Retina Society's 55th Annual Scientific Meeting Nov. 2 to 5, Verana Health®—a digital health company elevating quality in real-world data—will present findings on two separate studies that utilize curated real-world data (RWD) from the American Academy of Ophthalmology (Academy) IRIS® Registry (Intelligent Research in Sight).

Key Points: 
  • treatment arms of the CATT trial using de-identified IRIS Registry data from a real-world population to compare treatment outcomes at one year to the monthly treatment arms of the CATT using patient-level clinical trial data.
  • Established in 2014, the IRIS Registry is one of the largest specialty society clinical data registries in all of medicine.
  • Using its clinician-informed and artificial intelligence-enhanced VeraQpopulation health data engine, Verana Health transforms structured and unstructured healthcare data into curated, disease-specific data modules, Qdata.
  • Verana Health's quality data and insights help drive progress in medicine to enhance the quality of care and quality of life for patients.

ASCENSIA LAUNCHES THE GLUCOCONTRO.ONLINE DIABETES MANAGEMENT AND ANALYTICS PLATFORM IN THE U.S.

Retrieved on: 
Wednesday, November 2, 2022

PARSIPPANY, N.J, Nov. 2, 2022 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOURblood glucose monitoring (BGM) system portfolio and exclusive distributor of EversenseContinuous Glucose Monitoring (CGM) Systems,has today launched its online diabetes management and analytics platform GlucoContro.online in the United States.

Key Points: 
  • PARSIPPANY, N.J, Nov. 2, 2022 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOURblood glucose monitoring (BGM) system portfolio and exclusive distributor of EversenseContinuous Glucose Monitoring (CGM) Systems,has today launched its online diabetes management and analytics platform GlucoContro.online in the United States.
  • Through this single platform, people with diabetes (PWDs) can gather, access and analyze their diabetes data online and seamlessly share it with their healthcare providers (HCPs) and caregivers.
  • The platform is intuitive and easy-to-use, and gathers data directly from the CONTOURDIABETES app, CONTOUR Cloud, or CONTOUR meters via a cable.
  • GlucoContro.online is just one of the ways in which Ascensia is supporting PWDs and HCPs to simplify life with diabetes."